Craig Robson, MD
Urology · Charlotte, NCNPI 1043495948
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,947 of the $4,048 with a category attached, or 72.8%. Boston Scientific accounts for 68.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,915 and has fallen 88.4% since, to $223 in 2025.
Across 36 payments — averaging $112.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Procept Biorobotics Corporation$984
- Cook Medical LLC$159
- Olympus America Inc.$57
- Endo USA, Inc.$24
- Medline Industries LP$17
- plus $30 from 2 others
What the payments were for
- Travel & lodging$2,94773%
- Food & beverage$1,10127%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 23 | $2,777 |
| Procept Biorobotics Corporation | 3 | $984 |
| Cook Medical LLC | 3 | $159 |
| Olympus America Inc. | 3 | $57 |
| Endo USA, Inc. | 1 | $24 |
| Medline Industries LP | 1 | $17 |
| Vertex | 1 | $17 |
| Endo Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,048 in reported general payments places this provider in the 60th percentile of 434 urology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 42 | $799 |
| Finasteride | 27 | $359 |
| Tamsulosin Hcl | 36 | $267 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 19 | $174 |
| Ciprofloxacin Hcl | 16 | $98 |
| Levofloxacin | 11 | $58 |
Paid to pharmacies, not to this prescriber.
Other urology in Charlotte
- Michael KennellyCharlotte$1.3M
- Manish PatelCharlotte$84K
- Kris GastonCharlotte$32K
- Todd CohenCharlotte$18K
- Ornob RoyCharlotte$17K
- Maxim McKibbenCharlotte$15K
- Robert LippittSmithfield$11.4M
- John KasparRaleigh$1.1M
- Judd MoulDurham$1M
- Daniel GeorgeDurham$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.